Practical Reviews

Results on the Evaluation of Liver and Spleen Volumes After Radioembolization

Background: Yttrium-90 radioembolization, TheraSpheres, or SIR-Spheres is being used to treat inoperable hepatic metastatic disease, hepatocellular cancer, and intrahepatic cholangiocarcinoma. There is a certain amount of microvascular injury that occurs in the non-target parts of the liver secondary to the effect of the radiation. Objective: To evaluate the magnitude of the damage to normal liver parenchyma by comparing the volume of the liver and spleen before and after radioembo more...
To view this content, you must be a logged in subscriber to
Please Login to view this content.